LAURUSLABS.NS Balance Sheet
Laurus Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹3,015.96 Cr. | ₹3,446.37 Cr. | ₹3,668.46 Cr. | ₹3,873.23 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹550.78 Cr. | ₹422.84 Cr. | ₹458.36 Cr. | ₹773.28 Cr. | CapitalWorkInProgress |
| Goodwill | ₹246.30 Cr. | ₹246.30 Cr. | ₹246.30 Cr. | ₹246.30 Cr. | Goodwill |
| Other Intangible Assets | ₹12.93 Cr. | ₹19.02 Cr. | ₹19.32 Cr. | ₹18.40 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹49.90 Cr. | ₹123.98 Cr. | ₹233.26 Cr. | ₹309.27 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹119.57 Cr. | ₹64.88 Cr. | ₹321.95 Cr. | ₹414.80 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹4,198.72 Cr. | ₹4,552.06 Cr. | ₹5,003.25 Cr. | ₹5,681.98 Cr. | NoncurrentAssets |
| Inventories | ₹1,684.81 Cr. | ₹1,845.41 Cr. | ₹1,936.54 Cr. | ₹2,342.16 Cr. | Inventories |
| Trade Receivables | ₹1,580.44 Cr. | ₹1,662.92 Cr. | ₹2,007.16 Cr. | ₹2,155.04 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹45.67 Cr. | ₹138.94 Cr. | ₹99.54 Cr. | ₹112.66 Cr. | CashAndCashEquivalents |
| Current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CurrentInvestments |
| Other Current Assets | ₹130.69 Cr. | ₹175.22 Cr. | ₹237.62 Cr. | ₹214.17 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹3,461.68 Cr. | ₹3,834.97 Cr. | ₹4,332.32 Cr. | ₹4,829.21 Cr. | CurrentAssets |
| Total Assets | ₹7,660.40 Cr. | ₹8,387.03 Cr. | ₹9,335.57 Cr. | ₹10,511.19 Cr. | Assets |
| Equity Share Capital | ₹107.73 Cr. | ₹107.79 Cr. | ₹107.85 Cr. | ₹107.97 Cr. | EquityShareCapital |
| Other Equity | ₹3,929.80 Cr. | ₹4,003.16 Cr. | ₹4,364.71 Cr. | ₹5,192.09 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹4,037.53 Cr. | ₹4,110.95 Cr. | ₹4,472.56 Cr. | ₹5,300.06 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹11.13 Cr. | ₹4.62 Cr. | ₹129.96 Cr. | ₹131.30 Cr. | NonControllingInterest |
| Total Equity | ₹4,048.66 Cr. | ₹4,115.57 Cr. | ₹4,602.52 Cr. | ₹5,431.36 Cr. | Equity |
| Long-term Borrowings | ₹761.42 Cr. | ₹798.23 Cr. | ₹645.58 Cr. | ₹611.34 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹1,179.48 Cr. | ₹1,159.18 Cr. | ₹1,193.33 Cr. | ₹1,444.40 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹1,210.55 Cr. | ₹1,708.82 Cr. | ₹2,047.50 Cr. | ₹1,786.15 Cr. | BorrowingsCurrent |
| Trade Payables | ₹710.65 Cr. | ₹1,051.24 Cr. | ₹958.49 Cr. | ₹1,252.09 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹227.96 Cr. | ₹144.25 Cr. | ₹101.12 Cr. | ₹161.95 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹2,432.26 Cr. | ₹3,112.28 Cr. | ₹3,539.72 Cr. | ₹3,635.43 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹7,660.40 Cr. | ₹8,387.03 Cr. | ₹9,335.57 Cr. | ₹10,511.19 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from LAURUSLABS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).